BioMarin Pharmaceutical, Inc. (BMRN)
61.40
+2.89
(+4.94%)
USD |
NASDAQ |
Nov 18, 16:00
61.40
0.00 (0.00%)
After-Hours: 19:29
BioMarin Pharmaceutical Total Return Level : 58.51 for Nov. 17, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 17, 2026 | 58.51 |
| November 16, 2026 | 57.99 |
| November 13, 2026 | 57.23 |
| November 12, 2026 | 56.70 |
| November 11, 2026 | 58.33 |
| November 10, 2026 | 57.13 |
| November 09, 2026 | 57.18 |
| November 06, 2026 | 56.03 |
| November 05, 2026 | 56.12 |
| November 04, 2026 | 57.13 |
| November 03, 2026 | 55.66 |
| November 02, 2026 | 57.44 |
| October 30, 2026 | 58.51 |
| October 29, 2026 | 57.49 |
| October 28, 2026 | 56.00 |
| October 27, 2026 | 55.35 |
| October 26, 2026 | 55.75 |
| October 23, 2026 | 55.95 |
| October 22, 2026 | 56.63 |
| October 21, 2026 | 55.21 |
| October 20, 2026 | 56.44 |
| October 19, 2026 | 54.67 |
| October 16, 2026 | 54.68 |
| October 15, 2026 | 56.05 |
| October 14, 2026 | 55.14 |
| Date | Value |
|---|---|
| October 13, 2026 | 54.38 |
| October 12, 2026 | 55.39 |
| October 09, 2026 | 54.80 |
| October 08, 2026 | 54.89 |
| October 07, 2026 | 55.20 |
| October 06, 2026 | 56.22 |
| October 05, 2026 | 57.54 |
| October 02, 2026 | 57.18 |
| October 01, 2026 | 58.44 |
| September 30, 2026 | 60.00 |
| September 29, 2026 | 59.87 |
| September 28, 2026 | 59.46 |
| September 25, 2026 | 60.26 |
| September 24, 2026 | 61.35 |
| September 23, 2026 | 62.21 |
| September 22, 2026 | 63.37 |
| September 21, 2026 | 64.06 |
| September 18, 2026 | 63.94 |
| September 17, 2026 | 65.08 |
| September 16, 2026 | 64.73 |
| September 15, 2026 | 64.45 |
| September 14, 2026 | 66.41 |
| September 11, 2026 | 65.68 |
| September 10, 2026 | 65.51 |
| September 09, 2026 | 64.41 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Exelixis, Inc. | 68.50 |
| Ascendis Pharma A/S | 271.19 |
| Alnylam Pharmaceuticals, Inc. | 156.50 |
| Anika Therapeutics, Inc. | 12.85 |
| Arrowhead Pharmaceuticals, Inc. | 42.99 |